2010
Predictors of Treatment Attrition Among an Outpatient Clinic Sample of Youths With Clinically Significant Anxiety
Gonzalez A, Weersing VR, Warnick EM, Scahill LD, Woolston JL. Predictors of Treatment Attrition Among an Outpatient Clinic Sample of Youths With Clinically Significant Anxiety. Administration And Policy In Mental Health And Mental Health Services Research 2010, 38: 356-367. PMID: 20976618, PMCID: PMC3145079, DOI: 10.1007/s10488-010-0323-y.Peer-Reviewed Original ResearchConceptsOutpatient mental health clinicClinician-rated dropoutTreatment attritionComorbid depression symptomsMental health clinicsPhases of treatmentOutpatient clinic sampleClinical characteristicsComorbid depressionHealth clinicsSignificant symptomsDepression symptomsSignificant anxietyClinic sampleDepressed youthAnxious youthPsychotherapy servicesRate of attritionHigh rateSymptomsTreatmentPT definitionsEthnic minority families
1999
Case Study: Missed Diagnosis and Mistreatment of Unrecognized Comorbid Graves Disease
WOOLSTON J, CARACANSI A. Case Study: Missed Diagnosis and Mistreatment of Unrecognized Comorbid Graves Disease. Journal Of The American Academy Of Child & Adolescent Psychiatry 1999, 38: 861-864. PMID: 10405504, DOI: 10.1097/00004583-199907000-00016.Peer-Reviewed Original ResearchConceptsAttention deficit hyperactivity disorderGraves' diseaseTourette's disorderDiabetes mellitus type IComorbid medical conditionsMellitus type ILack of diagnosisMedical conditionsMissed diagnosisPsychiatric disordersHyperactivity disorderDisordersDiseaseType IDiagnosisType IITreatmentSyndromeSymptoms
1994
Clozapine in the Treatment of a Young Adolescent with Schizophrenia
JACOBSEN L, WALKER M, EDWARDS J, CHAPPELL P, WOOLSTON J. Clozapine in the Treatment of a Young Adolescent with Schizophrenia. Journal Of The American Academy Of Child & Adolescent Psychiatry 1994, 33: 645-650. PMID: 8056727, DOI: 10.1097/00004583-199406000-00004.Peer-Reviewed Original Research
1990
Fluoxetine Treatment of Children and Adolescents with Tourette's and Obsessive Compulsive Disorders: Preliminary Clinical Experience
RIDDLE M, HARDIN M, KING R, SCAHILL L, WOOLSTON J. Fluoxetine Treatment of Children and Adolescents with Tourette's and Obsessive Compulsive Disorders: Preliminary Clinical Experience. Journal Of The American Academy Of Child & Adolescent Psychiatry 1990, 29: 45-48. PMID: 2295577, DOI: 10.1097/00004583-199001000-00008.Peer-Reviewed Original ResearchConceptsObsessive-compulsive disorderPreliminary clinical experiencePrimary obsessive-compulsive disorderTourette syndromeClinical experienceSelective serotonin uptake inhibitorMild gastrointestinal symptomsSerotonin uptake inhibitorEfficacy of fluoxetineCompulsive disorderFluoxetine administrationGastrointestinal symptomsFluoxetine treatmentResponder rateUptake inhibitorFluoxetineObsessive-compulsive symptomsPatientsAdverse effectsFluoxetine hydrochlorideSyndromeChildrenSymptomsOCD groupAdolescents
1989
Fluoxetine Overdose in an Adolescent
RIDDLE M, BROWN N, DZUBINSKI D, JETMALANI A, LAW Y, WOOLSTON J. Fluoxetine Overdose in an Adolescent. Journal Of The American Academy Of Child & Adolescent Psychiatry 1989, 28: 587-588. PMID: 2788642, DOI: 10.1097/00004583-198907000-00019.Peer-Reviewed Original Research
1988
Desipramine Treatment of Boys with Attention-Deficit Hyperactivity Disorder and Tics: Preliminary Clinical Experience
RIDDLE M, HARDIN M, CHO S, WOOLSTON J, LECKMAN J. Desipramine Treatment of Boys with Attention-Deficit Hyperactivity Disorder and Tics: Preliminary Clinical Experience. Journal Of The American Academy Of Child & Adolescent Psychiatry 1988, 27: 811-814. PMID: 3198572, DOI: 10.1097/00004583-198811000-00027.Peer-Reviewed Original ResearchConceptsAttention deficit hyperactivity disorderGlobal improvement ratingTourette syndromeTic symptomsDMI treatmentHyperactivity disorderCommon side effectsChronic tic disorderPreliminary clinical experienceSymptoms of ADHDDesipramine treatmentMild tachycardiaImprovement ratingStandard treatmentClinical evaluationTic disordersFamily historyCNS stimulantsSide effectsClinical experiencePatientsMarked reductionRating ScaleDesipramineSymptoms